On August 30, 2023, Propanc Biopharma, Inc. closed the transaction. The transaction included participation from a single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00085 USD | -15.00% | -10.00% | -92.50% |
1st Jan change | Capi. | |
---|---|---|
-92.50% | 1L | |
+30.03% | 68TCr | |
+30.34% | 57TCr | |
-3.92% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.01% | 17TCr |
- Stock Market
- Equities
- PPCB Stock
- News Propanc Biopharma, Inc.
- Propanc Biopharma, Inc. announced that it has received $0.12 million in funding